FDA panel backs previously rejected obesity pill
Wednesday, February 22, 2012 - 17:00
in Health & Medicine
(AP) -- A panel of advisers to the Food and Drug Administration overwhelmingly backed approval for a highly anticipated anti-obesity pill from Vivus Inc., a drug which the FDA previously rejected due to safety concerns.